33 clinical MCQs in Basic Pharmacology II. Which process involves the transfer of a drug from its site of administration to the blood. Kenya, Africa and...
Q1. Which process involves the transfer of a drug from its site of administration to the blood stream?
Answer: Absorption
Explanation: Absorption is the movement of a drug from its site of administration into the bloodstream. This process is essential for the drug to reach systemic circulation and eventually its site of action. --- ---
Q2. Receptor agonists result in a drug response.
Answer: True
Explanation: Receptor agonists bind to receptors and activate them, producing a biological response. This is the mechanism by which many drugs exert their therapeutic effects. --- ---
Q3. Glomerular filtration of a drug is affected by its
Answer: Plasma protein binding
Explanation: Only free (unbound) drug molecules can be filtered through the glomerulus. Drugs bound to plasma proteins are too large to pass through the glomerular membrane, so plasma protein binding directly affects glomerular filtration. --- ---
Q4. For the calculation of the volume of distribution (Vd) one must take into account
Answer: Concentration of a substance in plasma
Explanation: Volume of distribution (Vd) is calculated using the formula: Vd = Dose / Plasma concentration. It represents the theoretical volume needed to contain the total amount of drug at the same concentration as in plasma. --- ---
Q5. This illustration below is concerned with which factor that influences the response to drug therapy.
Answer: Rate of metabolism and excretion
Explanation: The illustration focuses on pharmacokinetics (how the body processes the drug), not pharmacodynamics (drug effects). Metabolism and excretion are pharmacokinetic processes that determine drug concentration over time. --- ---
Q6. The strength of the drug is related to the dose of the drug.
Answer: True
Explanation: Strength refers to the amount of drug in a dosage form (e.g., 500 mg tablet). Higher doses contain more drug and therefore have greater strength, though this is different from potency, which is a comparative measure. --- ---
Q7. What does "pharmacokinetics" include?
Answer: Drug biotransformation in the organism
Explanation: Pharmacokinetics describes what the body does to the drug, including absorption, distribution, metabolism (biotransformation), and excretion (ADME). --- ---
Q8. Drugs which undergo high degree of first-pass metabolism in liver
Answer: Have low oral bioavailability
Explanation: First-pass metabolism occurs when orally administered drugs are metabolized in the liver before reaching systemic circulation, reducing the amount of active drug available and thus decreasing oral bioavailability. --- ---
Q9. Bioavailability of drug refers to
Answer: None of the choices
Explanation: Bioavailability is the percentage of administered dose that reaches systemic circulation in the UNCHANGED (active) form, not "changed form" as stated in option E. None of the provided options correctly defines bioavailability. --- ---
Q10. Receptor antagonists result in a drug response. Choices
Answer: False
Explanation: Receptor antagonists bind to receptors but do not activate them. They block the receptor and prevent agonists from binding, thereby inhibiting a response rather than producing one. --- ---
Q11. Which of the following are sources for making drugs?
Answer: All the choices
Explanation: Drugs can be derived from multiple sources including animals (e.g., insulin), plants (e.g., morphine), and synthetic/chemical synthesis (e.g., aspirin). Modern pharmaceuticals use all these sources. --- ---
Q12. Which process affects bioavailability?
Answer: Absorption
Explanation: Bioavailability is primarily determined by absorption and first-pass metabolism. The extent and rate of absorption directly affect how much drug reaches systemic circulation. --- ---
Q13. Biotransformation of drugs is primarily directed to
Answer: Convert lipid soluble drugs into non-lipid soluble metabolites
Explanation: Biotransformation (metabolism) typically converts lipid-soluble drugs into more water-soluble (non-lipid soluble) metabolites, facilitating their excretion through urine or bile. --- ---
Q14. The volume of distribution (Vd) relates to
Answer: Single to a daily dose of an administrated drug
Explanation: Volume of distribution is the theoretical volume necessary to contain the total amount of administered drug at the same concentration observed in blood plasma. It indicates the extent of drug distribution in body tissues. --- ---
Q15. The reasons determining bioavailability are
Answer: Extent of absorption and hepatic first-pass effect
Explanation: Bioavailability is primarily determined by how much drug is absorbed and how much undergoes first-pass metabolism in the liver before reaching systemic circulation. --- ---
Q16. All of the following statements about efficacy and potency are true EXCEPT
Answer: The ED50 is a measure of drug's efficacy
Explanation: ED50 (effective dose in 50% of population) is a measure of potency, not efficacy. Efficacy refers to the maximum effect a drug can produce, regardless of dose. --- ---
Q17. Which of the following cytochrome P450 isoenzymes is involved in the metabolism of largest number of drugs in human beings and has been implicated in some dangerous drug interactions
Answer: CYP 3A4
Explanation: CYP3A4 is responsible for metabolizing approximately 50% of all drugs and is frequently involved in clinically significant drug-drug interactions. --- ---
Q18. A prodrug is
Answer: An inactive drug that is transformed in the body to an active metabolite
Explanation: A prodrug is administered in an inactive or less active form and is metabolized in the body to produce the active drug. This approach can improve drug absorption, distribution, or reduce side effects. --- ---
Q19. Which process is concerned with the blood brain barrier, tissue storage and plasma protein binding?
Answer: Distribution
Explanation: Distribution involves the movement of drug from circulation to tissues and is affected by barriers (like blood-brain barrier), tissue binding, and plasma protein binding. --- ---
Q20. Which of the following is pharmacokinetic parameter used to monitor the elimination phase of a drug?
Answer: Plasma half life
Explanation: Plasma half-life (t½) is the time required for the plasma concentration of a drug to decrease by 50%. It is the primary parameter used to monitor and characterize drug elimination. --- ---
Q21. The most commonly occurring conjugation reaction for drugs and their metabolites is
Answer: Glucuronidation
Explanation: Glucuronidation is the most common Phase II conjugation reaction, involving the addition of glucuronic acid to drugs or their metabolites, making them more water-soluble for excretion. --- ---
Q22. What is the reason of complicated penetration of some drugs through brain-blood barrier?
Answer: Absence of pores in the brain capillary endothelium
Explanation: The blood-brain barrier has tight junctions between endothelial cells with no pores, making it difficult for many drugs to penetrate. Only lipid-soluble drugs or those with specific transporters can cross easily. --- ---
Q23. Which process involves the drug being metabolized in the liver before reaching systemic circulation?
Answer: Metabolism
Explanation: This describes first-pass metabolism, where orally administered drugs are metabolized in the liver (or gut wall) before reaching systemic circulation, reducing bioavailability. --- ---
Q24. Correct statements listing characteristics of a particular route of drug administration include all of the following EXCEPT
Answer: Inhalation provides slow access to the general circulation
Explanation: Inhalation actually provides rapid access to systemic circulation due to the large surface area and rich blood supply of the lungs, not slow access. --- ---
Q25. Which process involves the passage of drug from the circulation to the tissue and site of its action?
Answer: Distribution
Explanation: Distribution is the process by which a drug reversibly moves from the bloodstream into tissues and the site of action. --- ---
Q26. High plasma protein binding
Answer: Generally makes the drug long acting
Explanation: Drugs highly bound to plasma proteins act as a reservoir, slowly releasing free drug as it is eliminated. This prolongs drug action and half-life. --- ---
Q27. If you double the dose, which part of the illustration below will concern you more before continuing drug therapy?
Answer: E - F. F - G. G
Explanation: A represents Cmax (peak concentration). Doubling the dose increases Cmax, bringing it closer to MTC (Minimum Toxic Concentration, labeled G), increasing the risk of toxicity. --- ---
Q28. What is pharmacology?
Answer: All of the choices
Explanation: Pharmacology is broadly the study of how chemical agents (drugs) affect biological systems, encompassing drug interactions with the body, effects, and toxicology. Multiple definitions can be correct. --- ---
Q29. This illustration below is concerned with what aspect of drug therapy when caring for a patient?
Answer: Administered dose
Explanation: The illustration displays pharmacokinetic characteristics (drug movement in the body), which are directly influenced by how much drug was administered, not the drug's pharmacodynamic effects. --- ---
Q30. If the patient has a faster absorption, which part of the illustration below will concern you more before continuing drug therapy?
Answer: E - F. F - G. G
Explanation: B represents onset time. Faster absorption means the drug will reach therapeutic levels more quickly, resulting in a shorter onset time, which could be a concern for monitoring. --- ---
Q31. The plasma protein bound fraction of a drug
Answer: Is not available for metabolism unless actively extracted by the liver
Explanation: Only free (unbound) drug is available for metabolism, distribution, and elimination. Protein-bound drug is pharmacologically inactive unless the liver can actively extract it. --- ---
Q32. The strength of the drug is related to the concentration of the drug.
Answer: True
Explanation: Strength describes the amount/concentration of drug in a dosage form (e.g., 500 mg/tablet or 250 mg/5 mL). Higher concentrations mean greater strength of the preparation. --- ---
Q33. If the patient has a faster elimination process, which part of the illustration below will concern you more before starting drug therapy?
Answer: E - F. F - G. G
Explanation: E represents duration of action. Faster elimination shortens the duration of action, meaning drug concentrations may fall below the MEC (Minimum Effective Concentration) more quickly, potentially making the therapy subtherapeutic. --- Quiz Score: 35/36